Highlights
- Market Cap
- $3.93B
- Enterprise Value
- $4.45B
- EPS (TTM)
- -$1.37
- Total Revenue (TTM)
- $747.14M
- Gross Profit (TTM)
- $527.25M
- EBITDA (TTM)
- -$21.66M
- Year Range
- $92.52 - $212.00
- Target Price
- $217.91
- ROA (TTM)
- -4.37%
- ROE (TTM)
- -29.17%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in iRhythm Technologies, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
iRhythm Technologies, Inc. (IRTC) has returned -33.49% so far this year and 12.74% over the past 12 months.
iRhythm Technologies, Inc.
- 1D
- 3.34%
- 1M
- -11.76%
- YTD
- -33.49%
- 6M
- -31.38%
- 1Y
- 12.74%
- 3Y*
- -1.64%
- 5Y*
- -2.97%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Oct 20, 2016, IRTC's average daily return is +0.14%, while the average monthly return is +2.63%. At this rate, your investment would double in approximately 2.2 years.
Historically, 53% of months were positive and 47% were negative. The best month was Aug 2020 with a return of +76.9%, while the worst month was Apr 2021 at -43.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 9 months.
On a daily basis, IRTC closed higher 51% of trading days. The best single day was Nov 3, 2021 with a return of +59.0%, while the worst single day was Apr 12, 2021 at -39.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -12.92% | -13.44% | -11.76% | -33.49% | |||||||||
| 2025 | 20.72% | 1.20% | -4.97% | 2.11% | 31.44% | 9.58% | -8.95% | 21.26% | 1.18% | 8.90% | 0.38% | -5.62% | 96.78% |
| 2024 | 11.90% | -0.94% | -2.23% | -5.53% | -19.50% | 22.03% | -19.87% | -17.82% | 4.74% | -2.42% | 20.05% | 3.69% | -15.76% |
| 2023 | 4.94% | 19.72% | 5.40% | 5.94% | -13.04% | -8.71% | 0.71% | -1.61% | -8.81% | -16.70% | 8.61% | 25.52% | 14.27% |
| 2022 | 6.07% | 3.56% | 21.81% | -21.65% | 14.17% | -23.30% | 43.14% | -4.64% | -15.04% | 1.76% | -14.46% | -14.10% | -20.41% |
| 2021 | -29.00% | -4.47% | -13.70% | -43.93% | -3.08% | -12.07% | -22.95% | -6.49% | 22.51% | 19.77% | 50.56% | 11.45% | -50.39% |
Benchmark Metrics
iRhythm Technologies, Inc. has an annualized alpha of 21.02%, beta of 1.17, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since October 21, 2016.
- This stock captured 111.99% of S&P 500 Index gains but only 92.41% of its losses — a favorable profile for investors.
- R² of 0.12 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 21.02%
- Beta
- 1.17
- R²
- 0.12
- Upside Capture
- 111.99%
- Downside Capture
- 92.41%
Return for Risk
Risk / Return Rank
IRTC ranks 49 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for iRhythm Technologies, Inc. (IRTC) and compare them to a chosen benchmark (S&P 500 Index).
| IRTC | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.28 | 0.90 | -0.62 |
Sortino ratioReturn per unit of downside risk | 0.81 | 1.39 | -0.58 |
Omega ratioGain probability vs. loss probability | 1.10 | 1.21 | -0.11 |
Calmar ratioReturn relative to maximum drawdown | 0.31 | 1.40 | -1.09 |
Martin ratioReturn relative to average drawdown | 0.88 | 6.61 | -5.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore IRTC risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the iRhythm Technologies, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iRhythm Technologies, Inc. was 84.39%, occurring on Aug 19, 2021. The portfolio has not yet recovered.
The current iRhythm Technologies, Inc. drawdown is 56.04%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -84.39% | Jan 21, 2021 | 147 | Aug 19, 2021 | — | — | — |
| -43.01% | Mar 6, 2020 | 9 | Mar 18, 2020 | 29 | Apr 29, 2020 | 38 |
| -37.92% | Sep 17, 2018 | 69 | Dec 24, 2018 | 45 | Mar 1, 2019 | 114 |
| -37.33% | Mar 4, 2019 | 205 | Dec 20, 2019 | 49 | Mar 4, 2020 | 254 |
| -30.77% | Nov 16, 2020 | 14 | Dec 4, 2020 | 30 | Jan 20, 2021 | 44 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of iRhythm Technologies, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how iRhythm Technologies, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for IRTC relative to other companies in the Medical Devices industry. Currently, IRTC has a P/S ratio of 5.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for IRTC in comparison with other companies in the Medical Devices industry. Currently, IRTC has a P/B value of 25.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |